LILRA5/CD85f Protein, Human (HEK293, His-Avi)

LILRA5/CD85f Protein potentially triggers innate immune responses independently of recognizing class I MHC antigens. This unique feature suggests its distinctive role in the early defense against pathogens, operating through pathways not reliant on class I MHC antigen recognition. The precise molecular mechanisms of LILRA5/CD85f in innate immunity remain to be fully revealed, urging further exploration into its functional significance within the immune system. LILRA5/CD85f Protein, Human (HEK293, His-Avi) is the recombinant human-derived LILRA5/CD85f protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of LILRA5/CD85f Protein, Human (HEK293, His-Avi) is 227 a.a., with molecular weight of 38-50 kDa.

LILRA5/CD85f Protein is suggested to potentially play a role in triggering innate immune responses, indicating its involvement in the early defense mechanisms against pathogens. However, it does not appear to have a role in recognizing any class I major histocompatibility complex (MHC) antigens. This distinctive feature suggests that LILRA5/CD85f may exert its immune-modulating effects through pathways independent of class I MHC antigen recognition, highlighting its unique role in the intricate landscape of innate immune responses. The specific molecular mechanisms underlying its participation in triggering innate immunity remain to be fully elucidated, warranting further exploration into its functional significance in the context of the immune system.

Human

HEK293

C-Avi;C-His

A6NI73 (G42-R268)

353514  [NCBI]

38-50 kDa

Greater than 95% as determined by Tris-Bis PAGE.

<1 EU/μg, determined by LAL method.